Hollencrest Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
Hollencrest Capital Management's RGEN Position: Q4 2025 in Review
Hollencrest Capital Management sold out of Repligen (RGEN) in Q4 2025, closing a stake of 100 shares — an estimated $13.4K sold.
Hollencrest Capital Management first reported a position in RGEN in Q4 2022 and held it in 12 quarters. The position peaked at $18.4K in Q1 2024. 474 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.
- Hollencrest Capital Management reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
- Hollencrest Capital Management sold 100 Repligen shares in Q4 2025, an estimated $13.4K.
- Hollencrest Capital Management first reported a position in Repligen in Q4 2022 and held it in 12 quarters.
- Hollencrest Capital Management's Repligen position peaked at $18.4K in Q1 2024.
- 474 funds tracked by Wall St. Rank held Repligen as of Q4 2025.
Based on Hollencrest Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.